111 results on '"A Linhart"'
Search Results
2. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
3. Restrictive cardiomyopathy: definition and diagnosis
4. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery
5. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases
6. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology
7. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS)
8. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics
9. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS)
10. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)
11. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)
12. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
13. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)
14. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
15. Do the ESC guidelines improve the treatment of acute myocardial infarction due to acute circumflex artery occlusion?
16. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases
17. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
18. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology
19. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
20. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA)
21. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
22. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases
23. Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis
24. Do the ESC guidelines improve the treatment of acute myocardial infarction due to acute circumflex artery occlusion?
25. Aortic remodelling in Fabry disease
26. P3673Electroanatomical mapping of right atrium in patients with pulmonary hypertension
27. P1455Atrial fibrillation detection by integrated trans-telephonic ECG monitoring after cryptogenic stroke in the years 2016–2018 in the Czech and Slovak Republics
28. Cardiac manifestations of Anderson–Fabry disease: results from the international Fabry outcome survey
29. P1920The relative length of late-enhanced gadolinium MRI gaps determines the risk of recurrence of atrial fibrillation after pulmonary vein isolation
30. P1455Atrial fibrillation detection by integrated trans-telephonic ECG monitoring after cryptogenic stroke in the years 2016–2018 in the Czech and Slovak Republics
31. P3673Electroanatomical mapping of right atrium in patients with pulmonary hypertension
32. P714Large inter-laboratory variability in the assessment of the presence of viral genomes in endomyocardial biopsies in patients with recently diagnosed dilated cardiomyopathy
33. P812Clinical validation of automatic local activation time annotation during idiopathic ventricular tachycardia ablation procedures
34. P1686Safety and efficacy of leadless pacemaker implant: a single centre experience
35. P1099Prompt initiation of agalsidase alfa therapy is associated with improved cardiovascular outcomes in the Fabry Outcome Survey
36. P5387Relaxin reduces cardiac inflammation and fibrosis and prevents post-infarction arrhythmia in cryoinfarcted mice
37. P5222Cardiac magnetic resonance using late gadolinium enhancement imaging and T1 mapping predicts poor outcome in patients with atrial fibrillation after catheter ablation therapy
38. P1116Image-based criteria to identify the presence of epicardial arrhythmic substrate in patients with transmural myocardial infarction
39. P2659The length but not the number of late-enhanced gadolinum MRI gaps was associated with increased risk of recurrences of atrial fibrillation (AF) after pulmonary vein isolation in paroxysmal AF patients
40. 66Comparison of gaps detected by delayed-enhancement cardiac magnetic resonance after radiofrequency and cryoballon ablation of paroxysmal atrial fibrillation: a case-control study
41. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
42. P1920The relative length of late-enhanced gadolinium MRI gaps determines the risk of recurrence of atrial fibrillation after pulmonary vein isolation
43. P5222Cardiac magnetic resonance using late gadolinium enhancement imaging and T1 mapping predicts poor outcome in patients with atrial fibrillation after catheter ablation therapy
44. P714Large inter-laboratory variability in the assessment of the presence of viral genomes in endomyocardial biopsies in patients with recently diagnosed dilated cardiomyopathy
45. P1099Prompt initiation of agalsidase alfa therapy is associated with improved cardiovascular outcomes in the Fabry Outcome Survey
46. P2659The length but not the number of late-enhanced gadolinum MRI gaps was associated with increased risk of recurrences of atrial fibrillation (AF) after pulmonary vein isolation in paroxysmal AF patients
47. P812Clinical validation of automatic local activation time annotation during idiopathic ventricular tachycardia ablation procedures
48. P5387Relaxin reduces cardiac inflammation and fibrosis and prevents post-infarction arrhythmia in cryoinfarcted mice
49. P1116Image-based criteria to identify the presence of epicardial arrhythmic substrate in patients with transmural myocardial infarction
50. P1686Safety and efficacy of leadless pacemaker implant: a single centre experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.